Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
The chronic liver diseases will slowly develop into liver fibrosis, cirrhosis, and even liver cancer if no proper control is performed with high efficiency. Up to now, the most effective treatment for end-stage liver diseases is liver transplantation. However, liver transplantation has the problems...
Saved in:
Main Authors: | Yun Gao, Xiushan Yin, Xiaomeng Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2022/1526217 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations)
by: A. A. Lavreniuk, et al.
Published: (2024-12-01) -
Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease
by: Sitong Yi, et al.
Published: (2023-01-01) -
Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design
by: Mari M. Kitahata, et al.
Published: (2015-01-01) -
Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases
by: Shan-jing Xu, et al.
Published: (2021-01-01) -
Recent Advances in Hydroxyapatite Scaffolds Containing Mesenchymal Stem Cells
by: John Michel, et al.
Published: (2015-01-01)